Literature DB >> 12717841

Expression of survivin protein in human colorectal carcinogenesis.

Lian-Jie Lin1, Chang-Qing Zheng, Yu Jin, Ying Ma, Wei-Guo Jiang, Tie Ma.   

Abstract

AIM: To identify the role of survivin in colorectal carcinogenesis and the relationship between Survivin and histological differentiation grade of colorectal carcinoma.
METHODS: Immunohistochemical staining of survivin by using the monoclonal antibody was performed by the standard streptavidin-peroxidase (SP) technique for the 188 paraffin sections which included 30 normal colorectal mucosas, 41 adenomas with low grade dysplasia, 30 adenomas with high grade dysplasia, and 87 colorectal carcinomas which were classified as high, middle and low differentiated subgroups which included 33, 28, 26 cases respectively.
RESULTS: Expression of survivin was observed in the cytoplasm of adenoma with dysplasia and colorectal carcinoma cells. No immunoreactivity of survivin was seen in normal mucosas. The positive rate of survivin increased in the transition from normal mucosas to adenomas with low grade dysplasia to high grade dysplasia/ carcinomas (0.0 %, 31.7 %, 56.7 % and 63.2% respectively). But the difference between high grade dysplasia and carcinomas had no statistical significance. Positive rate was not related to histological differentiation grade of colorectal carcinoma. Moreover, there was no correlation between histological differentiation grade of colorectal carcinoma and immunoreactive intensity of survivin.
CONCLUSION: The expression of survivin is the essential event in the early stage of colorectal carcinogenesis and plays an important role in the transition sequence and it is not related to histological differentiation grade of colorectal carcinoma. It thus may provide a new diagnostic and therapeutic target in colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12717841      PMCID: PMC4611408          DOI: 10.3748/wjg.v9.i5.974

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  36 in total

1.  Bcl-2 can promote p53-dependent senescence versus apoptosis without affecting the G1/S transition.

Authors:  Vincent Rincheval; Flore Renaud; Christophe Lemaire; Nelly Godefroy; Pascale Trotot; Viviane Boulo; Bernard Mignotte; Jean-Luc Vayssière
Journal:  Biochem Biophys Res Commun       Date:  2002-10-25       Impact factor: 3.575

2.  The combined treatment of aspirin and radiation induces apoptosis by the regulation of bcl-2 and caspase-3 in human cervical cancer cell.

Authors:  Kye Young Kim; Ji Yeon Seol; Geong-A Jeon; Myeong Jin Nam
Journal:  Cancer Lett       Date:  2003-01-28       Impact factor: 8.679

3.  Quick quantitative analysis of gene dosages associated with prognosis in neuroblastoma.

Authors:  T Tajiri; S Tanaka; K Shono; Y Kinoshita; Y Fujii; S Suita; K Ihara; T Hara
Journal:  Cancer Lett       Date:  2001-05-10       Impact factor: 8.679

4.  Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin.

Authors:  D S O'Connor; D Grossman; J Plescia; F Li; H Zhang; A Villa; S Tognin; P C Marchisio; D C Altieri
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

5.  Survivin expression in laryngeal squamous cell carcinomas and its prognostic implications.

Authors:  Youyi Dong; Li Sui; Yasuo Watanabe; Katsuyoshi Sugimoto; Masaaki Tokuda
Journal:  Anticancer Res       Date:  2002 Jul-Aug       Impact factor: 2.480

6.  Survivin expression correlates with clinical stage, histological grade, invasive behavior and survival rate in endometrial carcinoma.

Authors:  Noriyuki Takai; Tami Miyazaki; Masakazu Nishida; Kaei Nasu; Isao Miyakawa
Journal:  Cancer Lett       Date:  2002-10-08       Impact factor: 8.679

7.  Expression of survivin in primary glioblastomas.

Authors:  Asha Das; Wan-Loo Tan; Jennifer Teo; Duncan R Smith
Journal:  J Cancer Res Clin Oncol       Date:  2002-04-24       Impact factor: 4.553

8.  Bax, Bcl-2, and p53 expression in endometrial cancer.

Authors:  Noriaki Sakuragi; Alaa-eldin Salah-eldin; Hidemichi Watari; Tomoo Itoh; Shoichi Inoue; Tetsuya Moriuchi; Seiichiro Fujimoto
Journal:  Gynecol Oncol       Date:  2002-09       Impact factor: 5.482

9.  Evaluation of p53 and Bcl-2 expression as prognostic markers in invasive cervical carcinoma stage IIb/III patients treated by radiotherapy.

Authors:  Deepali Jain; Radhika Srinivasan; Firuza D Patel; Subhash Kumari Gupta
Journal:  Gynecol Oncol       Date:  2003-01       Impact factor: 5.482

10.  Phosphorylation of p53, induction of Bax and activation of caspases during beta-lapachone-mediated apoptosis in human prostate epithelial cells.

Authors:  Yung Hyun Choi; Mi Jung Kim; Seung Yeon Lee; Youl-Nam Lee; Gyoo Yong Chi; Hyun Sup Eom; Nam Deuk Kim; Byung Tae Choi
Journal:  Int J Oncol       Date:  2002-12       Impact factor: 5.884

View more
  20 in total

1.  Risk factors for postoperative recurrence in patients with pathologically T1 colorectal cancer.

Authors:  Shuji Iida; Hirotoshi Hasegawa; Koji Okabayashi; Konosuke Moritani; Makio Mukai; Yuko Kitagawa
Journal:  World J Surg       Date:  2012-02       Impact factor: 3.352

2.  Induction of apoptosis of human colon cancer cells by siRNA recombinant expression vector targeting survivin gene.

Authors:  Ming Cai; Guobin Wang; Kaixiong Tao; Changxue Cai
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-02-18

3.  The X-linked inhibitor of apoptosis protein is an independent prognostic marker for rectal adenocarcinoma after preoperative chemoradiotherapy.

Authors:  Yi-Ting Chen; Shu-Chuan Tsao; Hung-Pei Tsai; Jaw-Yuan Wang; Chee-Yin Chai
Journal:  Virchows Arch       Date:  2016-02-25       Impact factor: 4.064

4.  Increased spontaneous apoptosis, but not survivin expression, is associated with histomorphologic response to neoadjuvant chemoradiation in rectal cancer.

Authors:  Dermot T McDowell; Fraser M Smith; John V Reynolds; Stephen G Maher; Collette Adida; Paul Crotty; Eoin F Gaffney; Donal Hollywood; Brian Mehigan; Richard B Stephens; M J Kennedy
Journal:  Int J Colorectal Dis       Date:  2009-07-11       Impact factor: 2.571

5.  Down-regulation of survivin suppresses uro-plasminogen activator through transcription factor JunB.

Authors:  Kyung Hee Lee; Eun Young Choi; Sung Ae Koh; Min Kyoung Kim; Kyeong Ok Kim; Si Hyung Lee; Byung Ik Jang; Se Won Kim; Sang Woon Kim; Sun Kyo Song; Joon Hyuk Choi; Jae-Ryong Kim
Journal:  Exp Mol Med       Date:  2011-09-30       Impact factor: 8.718

6.  Expression of survivin and its four splice variants in colorectal cancer and its clinical significances.

Authors:  Quan-Xing Ge; Yu-Yuan Li; Yu-Qiang Nie; Wen-Ge Zuo; Yan-Lei Du
Journal:  Med Oncol       Date:  2013-03-15       Impact factor: 3.064

7.  Expression of survivin and its significance in colorectal cancer.

Authors:  Wei-Chang Chen; Qiang Liu; Jian-Xin Fu; Su-Ya Kang
Journal:  World J Gastroenterol       Date:  2004-10-01       Impact factor: 5.742

8.  Prognostic factors in 165 elderly colorectal cancer patients.

Authors:  Ke-Jun Nan; Hai-Xia Qin; Guang Yang
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

9.  Expression of survivin in primary and metastatic gastric cancer cells obtained by laser capture microdissection.

Authors:  Zhen-Ning Wang; Hui-Mian Xu; Li Jiang; Xin Zhou; Chong Lu; Xue Zhang
Journal:  World J Gastroenterol       Date:  2004-11-01       Impact factor: 5.742

10.  Cotransfection of survivin and CD44v3 short hairpin RNAs affects proliferation, apoptosis, and invasiveness of colorectal cancer.

Authors:  Zhonghong Liu; Yonghang Guo; Juan Li; Jun Xu; Bingrong Liu
Journal:  Dig Dis Sci       Date:  2013-02-03       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.